Schonfeld Strategic Advisors LLC Amicus Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 302,858 shares of FOLD stock, worth $2.96 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

302,858

Previous 246,001 23.11%

Holding current value

$2.96 Million

Previous $2.44 Million 32.54%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $542,984 - $687,401	56,857 Added 23.11%	302,858 $3.23 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $1.52 Million - $1.97 Million	168,025 Added 215.48%	246,001 $2.44 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $891,265 - $1.11 Million	77,976 New	77,976 $918,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $977,244 - $1.74 Million	-156,861 Reduced 81.91%	34,639 $372,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $1.13 Million - $1.79 Million	143,200 Added 296.48%	191,500 $1.81 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $353,520 - $447,840	36,000 Added 292.68%	48,300 $558,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $294,432 - $362,378	-33,804 Reduced 73.32%	12,300 $119,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $156,105 - $404,856	-16,968 Reduced 26.9%	46,104 $455,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $1.36 Million - $2.5 Million	-100,619 Reduced 61.47%	63,072 $1.46 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $2.11 Million - $2.6 Million	163,691 New	163,691 $2,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $388,504 - $653,953	-58,598 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $1.08 Million - $1.55 Million	-144,574 Reduced 71.16%	58,598 $571,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $2.16 Million - $3.58 Million	-269,828 Reduced 57.05%	203,172 $1.63 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $4.98 Million - $6.55 Million	454,600 Added 2470.65%	473,000 $5.9 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $528,104 - $732,192	-52,600 Reduced 74.08%	18,400 $250,000
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $594,980 - $954,240	71,000 New	71,000 $680,000
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $2.61 Million - $3.39 Million	-198,597 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $2.43 Million - $3.03 Million	176,962 Added 817.94%	198,597 $2.99 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $750,062 - $973,701	-59,957 Reduced 73.48%	21,635 $311,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $957,890 - $1.29 Million	81,592	81,592 $1.23 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Amicus Therapeutics, Inc. Transaction History